Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.77
0.06 (3.51%)
At close: Aug 15, 2025, 2:44 PM
13F Institute Ownership
Total Institutes of 45 in Inhibikase Therapeutics expanded their positions with an increase of 14 investors compared to the previous quarter. A reduction of 4.74M shares, as total invested capital declined by $63.44M with ownership percentage dropping from 211.11% to 50.62%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Sands Capital Ventures, LLC | 12.23% | 10.95M | +0.00% | 23.98M | 5.86% | May 14, 2025 |
| Soleus Capital Management, L.p... | 7.06% | 6.33M | +0.00% | 13.85M | 1.00% | May 15, 2025 |
| Perceptive Advisors LLC | 6.62% | 5.92M | +0.00% | 12.98M | 0.46% | Aug 06, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.